NCT02065401 - Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt) | Biotech Hunter

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 19, 2014

Study Completion Date

March 19, 2014

Conditions

Healthy

Interventions

DRUG

Deferitazole (disodium salt, granule)

Single oral dose of 1500 mg administered on Day 1

DRUG

Deferitazole (disodium salt, tablet)

Single oral dose of 1500 mg administered on Day 1

DRUG

Deferitazole (magnesium hydroxide salt)

Single oral dose of 2400 mg administered on Day 1

Trial Locations (1)

Clinical Pharmacology of Miami, Miami